第18/2023号法律
| 第18/2023号法律 修改第17/2009号法律《禁止不法生产、贩卖和吸食麻醉药品及精神药物》 2023年11月20日 |
| 《第18/2023号法律》经立法会于2023年11月7日通过本法律，行政长官贺一诚于2023年11月9日发布本法律，并于2023年11月20日刊登于《澳门特别行政区公报》。 |
立法会根据《澳门特别行政区基本法》第七十一条（一）项，制定本法律。
第一条 修改第17/2009号法律的附表
编辑一、在经第4/2014号法律、第10/2016号法律、第10/2019号法律、第22/2020号法律及第10/2021号法律修改的第17/2009号法律第四条第二款所指的表一A、表二A、表二B及表二C中分别增加以下物质，该等物质载于作为本法律组成部分的附件一：
（一）表一A：
（1）奥列巴文；
（2）邻氟芬太尼；
（3）异硝氮烯；
（4）溴啡；
（5）甲硝苯；
（二）表二A：
（1）3-甲氧基苯环利定；
（2）二苯基乙基哌啶；
（三）表二B：
（1）CUMYL-PEGACLON；
（2）MDMB-4en-PINACA；
（四）表二C：氟胺酮。
二、在第17/2009号法律第四条第四款所指的表四中，增加三种物质：氯氮唑仑、二氯西泮及氟溴唑仑；该等物质载于作为本法律组成部分的附件一。
三、在第17/2009号法律第四条第五款所指的表五中，增加三种物质：4-AP、1-boc-4-AP及去甲芬太尼；该等物质载于作为本法律组成部分的附件一。
第二条 修改表述
编辑第17/2009号法律的中文文本所表述的“阿片叠”改为“阿片剂”。
第三条 取代
编辑一、第17/2009号法律第十一条第二款所指的每日用量参考表，由作为本法律组成部分的附件二所载每日用量参考表取代。
二、第17/2009号法律第四条所指的表一至表六，分别由作为本法律组成部分的附件三所载表一至表六取代。
第四条 生效
编辑本法律自公布翌日起生效。
二零二三年十一月七日通过。
立法会主席 高开贤
二零二三年十一月九日签署。
命令公布。
行政长官 贺一诚
附件一
编辑［第一条第一款（一）项所指者］ 表一A
编辑| 编号 | 中文名称 | 葡文名称 | 化学名称∕结构 |
|---|---|---|---|
| 133 | 奥列巴文 | Oripavina | 3-O-demethylthebaine |
| 134 | 邻氟芬太尼 | Orthofluorofentanyl | N-(2-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide |
| 135 | 异硝氮烯 | Isotonitazene | N,N-diethyl-2-[2-(4-isopropoxybenzyl)-5-nitro--1H-benzo[d]imidazol-1-yl]ethan-1-amine |
| 136 | 溴啡 | Brorphine | 11-[1-(4-bromophenyl)ethyl]-piperidin-4-yl1,3-dihydro-2H-benzimidazol-2-one |
| 137 | 甲硝苯 | Metonitazene | N,N-diethyl-2-[2-(4-methoxybenzyl)-5-nitro-1H--benzo[d]imidazol-1-yl]ethan-1-amine |
［第一条第一款（二）项所指者］ 表二A
编辑| 编号 | 中文名称 | 葡文名称 | 化学名称∕结构 |
|---|---|---|---|
| 43 | 3-甲氧基苯环利定 | 3-Methoxyphencyclidine | 1-[1-(3-methoxyphenyl)cyclohexyl]piperidine |
| 44 | 二苯基乙基哌啶 | Diphenidine | 1-(1,2-diphenylethyl)piperidine |
［第一条第一款（三）项所指者］ 表二B
编辑| 编号 | 中文名称 | 葡文名称 | 化学名称∕结构 |
|---|---|---|---|
| 39 | CUMYL-PEGACLON | CUMYL-PEGACLON | 5-pentyl-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one |
| 40 | MDMB-4en-PINACA | MDMB-4en-PINACA | methyl 3,3-dimethyl-2-[1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido]butanoate |
［第一条第一款（四）项所指者］ 表二C
编辑| 编号 | 中文名称 | 葡文名称 | 化学名称∕结构 |
|---|---|---|---|
| 14 | 氟胺酮 | 2-Fluorodeschloroketamine, 2-FDCK | 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one |
（第一条第二款所指者） 表四
编辑| 编号 | 中文名称 | 葡文名称 | 化学名称∕结构 |
|---|---|---|---|
| 65 | 氯氮唑仑 | Clonazolam | 6-(2-chlorophenyl)-1-methyl-8-nitro-4H- -benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine |
| 66 | 二氯西泮 | Diclazepam | 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3--dihydro-2H-benzo[e][1,4]diazepin-2-one |
| 67 | 氟溴唑仑 | Flubromazolam | 8-bromo-6-(2-fluorophenyl)-1-methyl-4H--benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine |
（第一条第三款所指者） 表五
编辑| 编号 | 中文名称 | 葡文名称 | 化学名称∕结构 |
|---|---|---|---|
| 23 | 4-AP | 4-AP | 4-piperidinamine, N-phenyl- |
| 24 | 1-boc-4-AP | 1-boc-4-AP | 4-(phenylamino)-1-piperidinecarboxylic acid, 1,1-dimethylethyl ester |
| 25 | 去甲芬太尼 | Norfentanyl | propanamide, N-phenyl-N-4-piperidinyl- |
附件二 （第三条第一款所指者） 每日用量参考表
编辑| 序号 | 最经常吸食的表一至表四所列植物、物质或制剂 | 表 | 每日参考用量【附注】 |
|---|---|---|---|
| 1. | 海洛因 | I-A | 0.25克【注1及注2】 |
| 2. | 美沙酮 | I-A | 0.1克【注2】 |
| 3. | 吗啡 | I-A | 0.2克 |
| 4. | 阿片（罂粟汁凝固物） | I-A | 1克【注3-（2）】 |
| 5. | 盐酸可卡因 | I-B | 0.2克【注2及注4】 |
| 6. | 可卡因（苯甲酰芽子碱甲酯） | I-B | 0.03克【注2及注4】 |
| 7. | 大麻（植物的叶，或其开花或结果的顶部） | I-C | 1克【注1】 |
| 8. | 大麻树脂 | I-C | 0.5克【注3-（3）及（4）】 |
| 9. | 大麻油 | I-C | 0.25克【注3-（5）】 |
| 10. | 苯环利定 | II-A | 0.01克【注3-（1）】 |
| 11. | 麦角二乙胺 | II-A | 0.0002克【注1】 |
| 12. | 亚甲二氧基甲基苯丙胺 | II-A | 0.15克【注3-（1）及（6）】 |
| 13. | 苯丙胺 | II-B | 0.2克【注1】 |
| 14. | 甲基苯丙胺 | II-B | 0.2克【注1】 |
| 15. | Δ-9-四氢大麻酚 | II-B | 0.05克 |
| 16. | 氯胺酮 | II-C | 0.6克【注3-（1）】 |
注：
1. 所指的参考量是按照国际麻醉品管制局（INCB — International Narcotics Control Board）的资料而制定。
2. 所指的参考量是按照有关惯常使用量的流行病学的资料而制定。
3. 所指的参考量为：
（1）官方药物文件内所指的每日用量；
（2）效力相等于可参考的滥用物质的用量；
（3）按大麻产品所含的四氢大麻酚的平均含量的变数所定的每日平均用量；
（4）平均浓度为百分之十的Δ-9-四氢大麻酚；
（5）平均浓度为百分之二十的Δ-9-四氢大麻酚；
（6）在医学文献内所指的含有介乎80毫克至160毫克纯正物质的惯常平均用量（ca. 2 mg/kg）。然而，某些物质亦有可能混有杂质（如替苯丙胺、咖啡因）或掺合了海洛因。
4. 由于盐酸可卡因及苯甲酰芽子碱甲酯的化学成分的效价存在明显不同，因此特别对两者订定了不同的用量。
附件三 （第三条第二款所指者）
编辑表一 A
编辑| 编号 | 中文名称 | 葡文名称 | 化学名称∕结构 |
|---|---|---|---|
| 1 | 乙酰-α-甲基芬太尼 | Acetil-alfa-metilfentanil | N-[1-(α-methylphenethyl)-4-piperidyl]acetanilide |
| 2 | 醋氢可待因 | Acetildiidrocodeína | 4,5-epoxy-3-methoxy-17-methylmorphina-6-ol acetate) |
| 3 | 醋美沙朵 | Acetilmetadol | 3-acetoxy-6-dimethylamino-4,4-diphenylheptane |
| 4 | 醋托啡 | Acetorfina | 3-O-acetyltetrahydro-7α-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine |
| 5 | 阿醋美沙朵 | Alfacetilmetadol | α-3-acetoxy-6-dimethylamino-4,4-diphenylheptane |
| 6 | α-美罗定 | Alfameprodina | α-3-ethyl-1-methyl-4-phenyl-4- propionoxypiperidine |
| 7 | α-美沙多 | Alfametadol | α-6-dimethylamino-4,4-diphenyl-3-heptanol |
| 8 | α-甲基芬太尼 | Alfa-metilfentanil | N-[1-( α-methylphenethyl)-4- piperidyl]propionanilide |
| 9 | α-甲基硫代芬太尼 | Alfa-metiltiofentanil | N-[1-[1-methyl-2-(2-thienyl)ethyl]-4-piperidyl]propionanilide |
| 10 | α-罗定 | Alfaprodina | α-1,3-dimethyl-4-phenyl-4-propionoxypiperidine |
| 11 | 阿芬他尼 | Alfentanil | N-[1-[2-(4-ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)-4-piperidinyl]- N-phenylpropanamide |
| 12 | 烯丙罗定 | Alilprodina | 3-allyl-1-methyl-4-phenyl-4-propionoxypiperidine |
| 13 | 氨苄哌替啶 | Anileridina | 1-p-aminophenethyl-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 14 | 联苯胺 | Benzetidina | 1-(2-benzyloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 15 | 苄吗啡 | Benzilmorfina | 3-benzylmorphine |
| 16 | β-乙酰美沙多 | Betacetilmetadol | β-3-acetoxy-6-dimethylamino-4,4-diphenylheptane |
| 17 | β-羟基芬太尼 | Beta-hidroxifentanil | N-[1-(β-hydroxyphenethyl)-4-piperidyl]propionanilide |
| 18 | β-羟基-3-甲基芬太尼 | Beta-hidroxi-3-metil fentanil | N-[1-(β-hydroxyphenethyl)-3-methyl-4-piperidyl]propionanilide |
| 19 | β-美罗定 | Betameprodina | β-3-ethyl-1-methyl-4-phenyl-4- propionoxypiperidine |
| 20 | β-美沙多 | Betametadol | β-6-dimethylamino-4,4-diphenyl-3-heptanol |
| 21 | β-普鲁汀 | Betaprodina | β-1,3-dimethyl-4-phenyl-4- propionoxypiperidine |
| 22 | 可待因 | Bezitramida | 1-(3-cyano-3,3-diphenylpropyl)-4-(2-oxo-3-propionyl-1-benzimidazolinyl)piperidine |
| 23 | 吗苯丁酯 | Butirato de dioxafetilo | ethyl-4-morpholino-2,2-diphenylbutyrate |
| 24 | 凯托米酮 | Cetobemidona | 4-m-hydroxyphenyl-1-methyl-4-propionylpiperidine |
| 25 | 氯尼他秦 | Clonitazeno | 2-(p-chlorobenzyl)-1-diethylaminoethyl-5-nitrobenzimidazole |
| 26 | 可待因 | Codeína | 3-methylmorphine |
| 27 | 可待因-N-氧化物 | Codeína-N-óxido | 3-methoxy-4,5-epoxy-6-hydroxy-17-methyl-7-morphinan-17-oxy-ol |
| 28 | 可多克辛 | Codoxina | dihydrocodeinone-6-carboxymethyloxime |
| 29 | 罂粟草浓缩物 –罂粟草生物碱经浓缩所得的质料。 |
Concentrado da cápsula de Papaver Somniferum L.– O produto obtido da cápsula da Papaver som niferum L. e submetido a processo para concentração dos seus alcalóides. |
|
| 30 | 地索吗啡 | Desomorfina | dihydrodeoxymorphine |
| 31 | 右旋吗拉胺 | Dextromoramida | (+)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]morpholine |
| 32 | 右旋丙氧吩 | Dextropropoxifeno | α-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-butanol propionate |
| 33 | 地恩丙胺 | Diampromida | N-[2-(methylphenethylamino)propyl]propionanilide |
| 34 | 二乙噻丁 | Dietiltiambuteno | 3-diethylamino-1,1-di(2'-thienyl)-1-butene |
| 35 | 地芬诺酯 | Difenoxilato | 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 36 | 氰苯哌酸 | Difenoxina | 1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotic acid |
| 37 | 双氢可待因 | Diidrocodeína | (5α,6α)-4,5-Epoxy-3-methoxy-17-methylmorphinan-6-ol |
| 38 | 双氢埃托啡 | Diidroetorfina | 7,8-dihydro-7α-[1-(R)-hydroxy-1-methylbutyl]-6,14-endo-ethanotetrahydrooripavine |
| 39 | 双氢吗啡 | Di-hidromorfina | (5α,6α)-4,5-Epoxy-17-methylmorphinan-3,6-diol |
| 40 | 地美庚醇 | Dimefeptanol | 6-dimethylamino-4,4-diphenyl-3-heptanol |
| 41 | 地美沙朵 | Dimenoxadol | 2-dimethylaminoethyl-1-ethoxy-1,1-diphenylacetate |
| 42 | 二甲噻丁 | Dimetiltiambuteno | 3-dimethylamino-1,1-di(2'-thienyl)-1-butene |
| 43 | 地匹哌酮 | Dipipanona | 4,4-diphenyl-6-piperidine-3-heptanone |
| 44 | 羟蒂巴酚 | Drotebanol | 3,4-dimethoxy-17-methylmorphinan-6 β,14-diol |
| 45 | 乙基甲嗯丁胺 | Etilmetiltiambuteno | 3-ethylmethylamino-1,1-di(2'-thienyl)-1-butene |
| 46 | 乙基吗啡 | Etilmorfina | 3-ethylmorphine |
| 47 | 依托尼秦 | Etonitazeno | 1-diethylaminoethyl-2-p-ethoxybenzyl-5-nitrobenzimidazole |
| 48 | 羟戊甲吗啡 | Etorfina | tetrahydro-7α-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine |
| 49 | 爱托失立汀 | Etoxeridina | 1-[2-(2-hydroxyethoxy)ethyl]-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 50 | 吩那多松 | Fenadoxona | 6-morpholino-4,4-diphenyl-3-heptanone |
| 51 | 非那丙胺 | Fenanpromida | N-(1-methyl-2-piperidinoethyl)propionanilide |
| 52 | 非那佐辛 | Fenazocina | 2'-hydroxy-5,9-dimethyl-2-phenethyl-6,7-benzomorphan |
| 53 | 吩诺吗凡口 | Fenomorfano | 3-hydroxy-N-phenethylmorphinan |
| 54 | 吩诺配立汀 | Fenopiridina | 1-(3-hydroxy-3-phenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 55 | 芬太尼 | Fentanil | 1-phenethyl-4-N-propionylanilinopiperidine |
| 56 | 吗啉乙基吗啡 | Folcodina | morpholinylethylmorphine |
| 57 | 呋替啶 | Furetidina | 1-(2-tetrahydrofurfuryloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 58 | 海洛因 | Heroína | diacetylmorphine |
| 59 | 二氢可待因酮 | Hidrocodona | dihydrocodeinone |
| 60 | 羟二氢吗啡 | Hidromorfinol | 14-hydroxydihydromorphine |
| 61 | 二氢吗啡酮 | Hidromorfona | dihydromorphinone |
| 62 | 羟基配西汀 | Hidroxipetidina | 4-m-hydroxyphenyl-1-methylpiperidine-4-carboxylic acid ethyl ester |
| 63 | 异美沙酮 | Isometadona | 6-dimethylamino-5-methyl-4,4-diphenyl-3-hexanone |
| 64 | 左旋吩纳西吗凡 | Levofenacilmorfano | (-)-3-hydroxy-N-phenacylmorphinan |
| 65 | 左旋美沙芬* | Levometorfano | (-)-3-methoxy-N-methylmorphinan |
| 66 | 左旋甲吗拉密特 | Levomoramide | (-)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]morpholine |
| 67 | 左旋吗喃* | Levorfanol | (-)-3-hydroxy-N-methylmorphinan |
| 68 | 美沙酮 | Metadona | 6-dimethylamino-4,4-diphenyl-3-heptanone |
| 69 | 美沙酮中间体 | Metadona,intermedi ário de | 4-cyano-2-dimethylamino-4,4-diphenylbutane |
| 70 | 美他佐辛 | Metazocina | 2'-hydroxy-2,5,9-trimethyl-6,7-benzomorphan |
| 71 | 甲基去氧吗啡 | Meildesorfina | 6-methyl-∆6-deoxymorphine |
| 72 | 甲基双氢吗啡 | Metildiidromorfina | 6-methyldihydromorphine |
| 73 | 3-甲基芬太尼 | 3-metilfentanil | N-(3-methyl-1-phenethyl-4-piperidyl)propionanilide |
| 74 | 3-甲基硫代芬太尼 | 3-metiltiofentanil | N-[3-methyl-1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide |
| 75 | 美托邦 | Metopão | 5-methyldihydromorphinone |
| 76 | 肉豆蔻苯基吗啡 | Mirofina | myristylbenzylmorphine |
| 77 | 吗酰胺中间体 | Moramida, intermediário de | 2-methyl-3-morpholino-1,1-diphenylpropane carboxylic acid |
| 78 | 吗乙哌 | Morferidina | 1-(2-morpholinoethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 79 | 吗啡 | Morfina | (5α,6α)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol |
| 80 | 吗啡, 含五价氮之吗啡之溴甲烷及其他衍生物 | Morfina, bromometilato e outros derivados da morfina com nitrogénio pentavalente | |
| 81 | 吗啡-N-氧化物 | Morfina-N-óxido | 3,6-dihydroxy-4,5-epoxy-17-methyl-morphinan-N-oxide |
| 82 | 仲氟代芬太尼 | MPPP | 1-methyl-4-phenyl-4-piperidinol propionate (ester) |
| 83 | 6-烟碱可待因 | Nicocodina | 6-nicotinylcodeine |
| 84 | 3,6-二烟酰吗啡 | Nicomorfina | 3,6-dinicotinylmorphine |
| 85 | 烟碱酰二可待因 | Nicodicodina | 6-nicotinyldihydrocodeine |
| 86 | 去甲乙酰美沙多 | Noracimetadol | (±)-α-3-acetoxy-6-methylamino-4,4-diphenylheptane |
| 87 | 去甲可待因 | Norcodeína | N-demethylcodeine |
| 88 | 左旋3-羟吗啡喃 | Norlevorfanol | (-)-3-hydroxymorphinan |
| 89 | 去甲美沙酮 | Normetadona | 6-dimethylamino-4,4-diphenyl-3-hexanone |
| 90 | 去甲吗啡 | Normorfina | demethylmorphine |
| 91 | 二苯哌己酮 | Norpipanona | 4,4-diphenyl-6-piperidino-3-hexanone |
| 92 | 阿片 -从罂粟壳取得之自行凝结的 ,且仅经必需之包装及运输程序处理而不论其吗啡含量之乳液。 |
Ópio- O suco coagulado espontaneamente obtido da cápsula da Papaver Som niferum L. e que não tenha sofrido mais do que as manipulações necessárias para o seu empacotamento e transporte, qualquer que seja o seu teor em morfina. |
|
| 93 | 阿片 多种生物碱之氯化物及溴化物之混合物。 |
Ópio Mistura de alcalóides sob a forma de cloridratos e brometos. |
|
| 94 | 羟二氢可待因酮 | Oxicodona | 14-hydroxydihydrocodeinone |
| 95 | 羟二氢吗啡酮 | Oximorfona | 14-hydroxydihydromorphinone |
| 96 | 仲氟代芬太尼 | Para-fluorofentanil | 4'-fluoro-N-(1-phenethyl-4-piperidyl)propionanilide |
| 97 | 1-苯乙基-4-苯基-4-哌啶丙酸盐 | PEPAP | 1-phenethyl-4-phenyl-4-piperidinol acetate (ester) |
| 98 | 陪替丁 | Petidina | 1-methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 99 | 陪替丁中间体A | Petidina, intermediário A da | 4-cyano-1-methyl-4-phenylpiperidine |
| 100 | 陪替丁中间体B | Petidina, intermediário B da | 4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 101 | 陪替丁中间体 | Petidina, intermediário C da | 1-methyl-4-phenylpiperidine-4-carboxylic acid |
| 102 | 匹密诺汀 | Piminodina | 4-phenyl-1-(3-phenylaminopropyl)piperidine-4-carboxylic acid ethyl ester |
| 103 | 哌腈米特 | Piritramida | 1-(3-cyano-3,3-diphenylpropyl)-4-(1-piperidino)piperidine-4-carboxylic acid amide |
| 104 | 普鲁亥他净 | Pro-heptazina | 1,3-dimethyl-4-phenyl-4-propionoxyazacycloheptane |
| 105 | 普鲁散立汀 | Properidina | 1-methyl-4-phenylpiperidine-4-carboxylic acid isopropyl ester |
| 106 | 丙吡胺 | Propiramo | N-(1-methyl-2-piperidinoethyl)-N-2-pyridylpropionamide |
| 107 | 外消旋甲吗凡 | Racemétorfano | (±)-3-methoxy-N-methylmorphinan |
| 108 | 外消旋吗拉密特 | Racemoramida | (±)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]morpholine |
| 109 | 外消旋吗凡 | Racemorfano | (±)-3-hydroxy-N-methylmorphinan |
| 110 | 雷米芬太尼 | Remifentanilo | 1-(2-methoxycarbonylethyl)-4-(phenylpropionylamino)piperidine-4-carboxylic acid methyl ester |
| 111 | 舒吩太尼 | Sufentanil | N-[4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide |
| 112 | 醋氢可酮 | Tabecão | acetyldihydrocodeinone |
| 113 | 蒂巴因 | Tebaína | (5α)-6,7,8,14-Tetradehydro-4,5-epoxy-3,6-dimethoxy-17-methylmorphinan |
| 114 | 替利定 | Tilidina | (±)-ethyl-trans-2-(dimethylamino)-1-phenyl-3-cyclohexene-1-carboxylate |
| 115 | 硫代芬太尼 | Tiofentanil | N-[1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide |
| 116 | 三甲利定 | Trimeperidina | 1,2,5-trimethyl-4-phenyl-4-propionoxypiperidine |
| 117 | 3,4-二氯-N-{[1-（二甲基氨基）环己基]甲基}苯甲酰胺 | AH-7921 | 3,4-dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide |
| 118 | 乙酰芬太尼 | Acetylfentanyl | N-[1-(2-phenylethyl)-4-piperidyl]-N-phenylacetamide |
| 119 | 1-环己基-4（1,2-二苯基乙基）哌嗪 | MT-45 | 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine |
| 120 | U-47700 | U-47700 | 3,4-dichloro-N-(2-dimethylamino-cyclohexyl)-N-methyl-benzamide |
| 121 | 丁酰芬太尼 | Butyrfentanyl | N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]butanamide |
| 122 | 卡芬太尼 | Carfentanil | methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate |
| 123 | 奥芬太尼 | Ocfentanil | N-(2-fluorophenyl)-2-methoxy-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide |
| 124 | 呋喃芬太尼 | Furanylfentanyl | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl] furan-2-carboxamide |
| 125 | 丙烯酰芬太尼 | Acryloylfentanyl (Acrylfentanyl) | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]prop-2-enamide |
| 126 | 4-氟异丁基芬太尼 | 4-Fluoroisobutyrfentanyl (4-FIBF, pFIBF) | N-(4-fluorophenyl)-N-(1-phenetylpiperidin-4-yl)isobutyramide |
| 127 | 四氢呋喃芬太尼 | Tetrahydrofuranylfentanyl (THF-F) | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl] tetrahydrofuran-2-carboxamide |
| 128 | 对氟丁酰芬太尼 | Parafluorobutyrylfentanyl | N-(4-Fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]butanamide |
| 129 | 甲氧基乙酰芬太尼 | Methoxyacetylfentanyl | 2-Methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide |
| 130 | 环丙基芬太尼 | Cyclopropylfentanyl | N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide |
| 131 | 巴豆酰芬太尼 | Crotonylfentanyl | (E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide |
| 132 | 戊酰芬太尼 | Valerylfentanyl | N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide |
| 133 | 奥列巴文 | Oripavina | 3-O-demethylthebaine |
| 134 | 邻氟芬太尼 | Orthofluorofentanyl | N-(2-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide |
| 135 | 异硝氮烯 | Isotonitazene | N,N-diethyl-2-[2-(4-isopropoxybenzyl)-5-nitro--1H-benzo[d]imidazol-1-yl]ethan-1-amine |
| 136 | 溴啡 | Brorphine | 11-[1-(4-bromophenyl)ethyl]-piperidin-4-yl1,3-dihydro-2H-benzimidazol-2-one |
| 137 | 甲硝苯 | Metonitazene | N,N-diethyl-2-[2-(4-methoxybenzyl)-5-nitro-1H--benzo[d]imidazol-1-yl]ethan-1-amine |
| 列于本附表之物质之具有特定化学名称之异构物，然不包括明确不列入本附表之异构物。 | |||
| 列于本附表之物质之各形式之酯类及醚类，然不包括列于其他附表之酯类及醚类。 | |||
| 列于本附表之物质之盐类，包括上述酯类、醚类及异构物之盐类，祇要属该等盐类之可能形式者。 | |||
| *右旋美沙芬(+)-3-甲氧基-N-甲基吗啡喃及右旋芬(+)-3-羟基-N-甲基吗啡喃均明确地不列入本表内。 | |||
表一 B
编辑| 编号 | 中文名称 | 葡文名称 | 化学名称∕结构 |
|---|---|---|---|
| 1 | 古柯叶- 可直接提取或透过化学方法获得可卡因之Erythroxilon coca (Lamark)叶、Erythroxilon nova-granatense (Morris) Hieronymus及其变种之叶、Eritroxiláceas科之叶、该属之其他品种之叶；古柯灌木叶，然不包括已完全提取出芽子碱、可卡因及芽子碱之任何其他衍生生物碱之古柯灌木叶。 |
Coca, folha de- As folhas de Erythroxilon coca (Lamark), da Erythroxilon nova-granatense (Morris) Hieronymus e suas variedades, da família das eritroxiláceas e as suas folhas, de outras espécies deste género, das quais se possa extrair a cocaína directamente, ou obter-se por transformações químicas; as folhas do arbusto de coca, excepto aquelas de que se tenha extraído toda a ecgonina, a cocaína e quaisquer outros alcalóides derivados da ecgonina. |
|
| 2 | 可卡因 | Cocaína | methyl ester of benzoylecgonine |
| 3 | 可卡因-D-可卡因之右旋异构体 | Cocaína-D - isómero dextrógiro de cocaína. | |
| 4 | 芽子碱- 及其酯类及可转变为芽子碱及可卡因之衍生物。 |
Ecgonina- e os seus ésteres e derivados que sejam convertíveis em ecgonina e cocaína. |
|
| 本附表所列复合物之所有可能存在之盐类，均视为列入本附表内。 | |||
表一 C
编辑| 编号 | 中文名称 | 葡文名称 | 化学名称∕结构 |
|---|---|---|---|
| 1 | 大麻- Cannabis sativa L.植物之叶,或其开花或结果之顶部, 然并未从中提取出不论被冠以何种名称之树脂者。 |
Canabis-folhas e sumidades floridas ou frutificadas da planta Cannabis Sativa L. da qual não se tenha extraído a resina, qualquer que seja a denominação que se lhe dê. | |
| 2 | 大麻树脂- 从大麻(cannabis) 植物取得的, 未经提炼或已提纯之分离树脂。 |
Canabis, resina de-resina separada, em bruto ou purificada, obtida a partir da planta Cannabis. | |
| 3 | 大麻油- 从大麻 (cannabis) 植物取得的, 未经提炼或已提纯之分离油类。 |
Canabis, óleo de-óleo separado, em bruto ou purificado, obtido a partir da planta Cannabis. | |
| 本附表所列复合物之所有可能存在之盐类，均视为列入本附表内。 | |||
表二 A
编辑| 编号 | 中文名称 | 葡文名称 | 化学名称∕结构 |
|---|---|---|---|
| 1 | 2,5-二甲氧基-4-溴苯己胺 | 2C-B | 4-bromo-2,5-dimethoxyphenethylamine |
| 2 | 丙硫苯乙胺 | 2C-T-7 | 4-propylthio-2,5-dimethoxyphenethylamine |
| 3 | 蟾酥碱 | Bufotenina | 3-[2-(Dimethylamino)ethyl]-1H-indol-5-ol |
| 4 | 卡西酮 | Catinona | (–)-(S)-2-aminopropiophenone |
| 5 | 二乙基色胺 | DET | 3-[2-(diethylamino)ethyl]indole |
| 6 | 二甲氧基苯丙胺 | DMA | (±)-2,5-dimethoxy-α-methylphenethylamine |
| 7 | 二甲羟吡喃 | DMHP | 3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol |
| 8 | 二甲基色胺 | DMT | 3-[2-(dimethylamino)ethyl]indole |
| 9 | 布苯丙胺 | DOB, Brolanfetamina | (±)-4-bromo-2,5-dimethoxy-α-methylphenethylamine |
| 10 | 二甲氧基乙基苯丙胺 | DOET | (±)-4-ethyl-2,5-dimethoxy-α-phenethylamine |
| 11 | 氨甲氧苯丙胺 | DOM, STP | 2,5-dimethoxy-α,4-dimethylphenethylamine |
| 12 | 二丙色胺 | DPT | N,N-dipropyltryptamine |
| 13 | 乙环利定 | Eticiclidina, PCE | N-ethyl-1-phenylcyclohexylamine |
| 14 | 乙基色胺 | Etriptamina | 3-(2-aminobutyl)indole |
| 15 | 苯环利定 | Fenciclidina, PCP | 1-(1-phenylcyclohexyl)piperidine |
| 16 | 麦角二乙胺，致幻剂，致幻剂-25 | Lisergida, LSD, LSD-25 | 9,10-didehydro-N,N-diethyl-6-methylergoline-8β-carboxamide |
| 17 | 2,5-二甲氧基苯丙胺 | MDA, Tenanfetamina | α-methyl-3,4-(methylenedioxy)phenethylamine |
| 18 | 二甲（甲烯二氧）苯乙胺 | MDMA | (±)-N,α-dimethyl-3,4-(methylenedioxy)phenethylamine |
| 19 | 甲羟芬胺 | MMDA | 5-methoxy-α-methyl-3,4-(methylenedioxy)phenethylamine |
| 20 | 三甲氧苯乙胺 | Mescalina | 3,4,5-trimethoxyphenethylamine |
| 21 | 4-甲基阿米雷司 | 4-metilaminorex | (±)-cis-2-amino-4-methyl-5-phenyl-2-oxazoline |
| 22 | 甲基卡西酮 | Metilcatinona | 2-(methylamino)-1-phenylpropan-1-one |
| 23 | 4-甲硫苯丙胺 | 4-MTA | α-methyl-4-methylthiophenethylamine |
| 24 | 乙芬胺 | MDE, N-etil MDA | (±)-N-ethyl-α-methyl-3,4-(methylenedioxy)phenethylamine |
| 25 | 羟芬胺 | N-hidroxi MDA | (±)-N-[α-methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine |
| 26 | 六氢大麻酚 | Para-hexilo | 3-hexyl-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol |
| 27 | 副甲氧基苯丙胺 | PMA | p-methoxy-α-methylphenethylamine |
| 28 | 甲氧基甲基安非他明 | PMMA | Paramethoxymethylamphetamine(=N-methyl-1-(4-methoxyphenyl)-2-aminopropane) |
| 29 | 西洛西宾 | Psilocibina | 3-[2-(dimethylamino)ethyl]indol-4-yl dihydrogen phosphate |
| 30 | 裸头草辛 | Psilocina, psilotsin | 3-[2-(dimethylamino)ethyl]indol-4-ol |
| 31 | 环丙胺吡咯烷 | Roliciclidina, PHP, PCPY | 1-(1-phenylcyclohexyl)pyrrolidine |
| 32 | 替诺环定 | Tenociclidina, TCP | 1-[1-(2-thienyl)cyclohexyl]piperidine |
| 33 | 三甲氧基苯丙胺 | TMA | (±)-3,4,5,-trimethoxy-α-methylphenethylamine |
| 34 | 卡西酮的衍生物*
- 任何在结构上可从2-氨基-1-苯基-1-丙酮通过以下方式衍生成之化合物： （1）在苯环上以不限数量之烷基、烷氧基、亚烷二氧基、卤代烷基或卤素取代，而不论生成物有否再在苯环上被一个或多个之单价取代基所取代； （2）在3位上以烷基取代； （3）在氮原子上以烷基、双烷基取代，或把氮原子纳入一个环状结构。 - 任何在结构上可从2-氨基-1-丙酮之1位上以各种单环或稠环（不包括苯环或亚烷二氧苯环）衍生成之化合物，不论其有否再用以下方式作取代： （1）在苯环或稠环上以不限数量之烷基、烷氧基、卤代烷基或卤素取代，而不论生成物有否再在环上被一个或多个之单价取代基所取代； （2）在3位上以烷基取代； （3）在2-氨基之氮原子上以烷基或双烷基取代，或把2-氨基之氮原子纳入一个环状结构。 |
Derivados da Catinona
- Qualquer composto derivado estruturalmente da 2-amino-1-phenyl-1-propanone por modificação de qualquer das seguintes formas: (1) por substituição de qualquer extensão no anel fenil pelos substituintes alcoíl, alcóxi, alquillenedioxi, haloalquil ou haleto, quer seja ou não ainda mais substituída no anel fenil por um ou mais substituintes univalentes; (2) por substituição na posição-3 com um substituinte alcoíl; (3) por substituição no átomo de azoto com os grupos alcoíl ou dialcoíl, ou por inclusão do átomo de azoto numa estrutura cíclica. - Qualquer composto derivado estruturalmente da 2-aminopropan-1-one por substituição na posição - 1 por qualquer sistema anelar monocíclico, ou policíclicos-fundidos (sem ser um sistema anelar fenil ou alquillenedioxifenil), se o composto é ou não: (1) por substituição de qualquer extensão no sistema anelar com substituintes alcoíl, alcóxi, haloalquil ou haleto, quer seja ou não ainda mais substituída no sistema anelar por um ou mais substituintes univalentes; (2) por substituição na posição – 3 por qualquer substituinte alcoíl; (3) por substituição do átomo 2-amino nitrogen pelos grupos alcoíl ou dialcoíl ou por inclusão do átomo 2-amino nitrogen numa estrutura cíclica. |
|
| 35 | 哌嗪的衍生物
- 1-苄基哌嗪。 - 任何在结构上可从1-苄基哌嗪或1-苯基哌嗪通过以下方式衍生成之化合物： （1）在哌嗪环的第2位氮原子上以烷基、苄基、卤代烷基或苯基取代； （2）在芳香环上以不限数量之烷基、烷氧基、亚烷二氧基、卤基或卤代烷基取代。 |
Derivados da Piperazina
- 1-Benzilpiperazina. - Qualquer composto estruturalmente derivado da 1-benzilpiperazina ou 1- fenilpiperazina por modificação de qualquer das seguintes maneiras: (1) por substituição do segundo átomo de azoto no anel piperazina com os grupos alcoíl, benzil, haloalquíl ou fenil; (2) por substituição em qualquer extensão do anel aromático com os grupos alcoíl, alcóxi alquilenedioxi, haleto ou haloalquil. |
|
| 36 | 墨西哥鼠尾草 -Salvia Divinorum植物 |
Salvia Divinorum | |
| 37 | 丹酚A | Salvinorina-A | (2S, 4aR, 6aR, 7R, 9S, 10aS, 10bR)-9-(acetyloxy)-2-(3-furanyl) dodecahydro-6a, 10b-dimethyl-4, 10-dioxo-2H-naphtho [2,1-c] pyran-7-carboxylic acid methyl ester |
| 38 | N-（2-甲氧基苄基）-2-（2,5-二甲氧基-4-溴苯基）乙胺 | 25B-NBOMe | 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine |
| 39 | N-（2-甲氧基苄基）-2-（2,5-二甲氧基-4-氯苯基）乙胺 | 25C-NBOMe | 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine |
| 40 | N-（2-甲氧基苄基）-2-（2,5-二甲氧基-4-碘苯基）乙胺 | 25I-NBOMe | 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine |
| 41 | 副甲基甲米雷司 | 4,4’Dimethylaminorex(4,4’-DMAR) | para-methyl-4-methylaminorex |
| 42 | DOC | DOC | 4-chloro-2,5-dimethoxyamfetamine |
| 43 | 3-甲氧基苯环利定 | 3-Methoxyphencyclidine | 1-[1-(3-methoxyphenyl)cyclohexyl]piperidine |
| 44 | 二苯基乙基哌啶 | Diphenidine | 1-(1,2-diphenylethyl)piperidine |
| 本附表所列物质之可能存在之盐类。 | |||
| 本附表所列物质之具有特定化学名称之异构物，但明确不列入本附表之异构物除外。 | |||
| *卡西酮的衍生物中，安非他酮明确地不列入本表内。 | |||
表二 B
编辑| 编号 | 中文名称 | 葡文名称 | 化学名称∕结构 |
|---|---|---|---|
| 1 | 安不定 | Amineptina | 7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid |
| 2 | 苯丙胺 | Anfetamina | (±)-α-methylphenethylamine |
| 3 | 去甲麻黄碱，(+)-降假麻黄碱 | Catina, (+)-nor-pseudo efedrina | (+)-(S)-α-[(S)-1-aminoethyl]benzyl alcohol |
| 4 | 右旋苯丙胺 | Dexanfetamina | (+)-α-methylphenethylamine |
| 5 | 屈大麻酚∆ - 9- 四氢大麻酚及其立体化学变异体 | Dronabinol delta-9-tetrahidrocana binol e seus variantes estereoquímicos | (6aR,10aR)- 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol |
| 6 | 苯双甲吗啉 | Fendimetrazina | (+)-(2S,3S)-3,4-dimethyl-2-phenylmorpholine |
| 7 | 芬乃他林 | Fenetilina | 7-[2-[(α-methylphenethyl)amino]ethyl]theophylline |
| 8 | 苯甲吗啉 | Fenmetrazina | 3-methyl-2-phenylmorpholine |
| 9 | 甲基苯乙基胺 | Fentermina | α,α-dimethylphenethylamine |
| 10 | 左旋苯丙胺 | Levanfetamina | (–)-(R)-α-methylphenethylamine |
| 11 | 左旋甲基苯丙胺 | Levometanfetamina | (–)-N,α-dimethylphenethylamine |
| 12 | 甲基苯丙胺 | Metanfetamina | (+)-(S)-N,α-dimethylphenethylamine |
| 13 | 外消旋甲基苯丙胺 | Metanfetamina, Racemato de | (±)-N,α-dimethylphenethylamine |
| 14 | 哌醋甲酯 | Metilfenidato | methyl α-phenyl-2-piperidine acetate |
| 15 | N,N-二甲基安非他命 | N,N-dimetanfetamina | N,N-dimethylamphetamine |
| 16 | 四氢大麻酚-右列异构体及其立体化学变异体。 | Tetraidrocanabinol-os isómeros e seus variantes estereoquímicos indicados na coluna seguinte. | 7,8,9,10-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
(9R,10aR)-8,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol (6aR,9R,10aR)-6a,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol (6aR,10aR)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol 6a,7,8,9-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol (6aR,10aR)-6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo[b,d]pyran-1-ol |
| 17 | 双苯哌丙醇 | Zipeprol | α-(α-methoxybenzyl)-4-(β-methoxyphenethyl)-1-piperazineethanol |
| 18 | 合成大麻素
- 任何在结构上可从3-（1-萘甲酰基）吲哚或 1-H-吲哚-3基-1-萘甲酮通过在吲哚环之氮原子上以烷基、链烯基、环烷甲基、环烷乙基或2-（4-吗啉基）乙基取代所生成之化合物，而不论生成物有否再在吲哚环或萘环以不限数量取代。 - 任何在结构上可从3-（1-萘甲酰基）吡咯通过在吡咯环之氮原子上以烷基、链烯基、环烷甲基、环烷乙基或2-（4-吗啉基）乙基取代所生成之化合物，而不论生成物有否再在吡咯环或萘环以不限数量取代。 - 任何在结构上可从1-（1-萘甲基）茚通过在茚环之3-位上以烷基、链烯基、环烷甲基、环烷乙基或2-（4-吗啉基）乙基取代所生成之化合物，而不论生成物有否再在茚环或萘环以不限数量取代。 - 任何在结构上可从3-苯乙酰基吲哚通过在吲哚环之氮原子上以烷基、链烯基、环烷甲基、环烷乙基或2-（4-吗啉基）乙基取代所生成之化合物，而不论生成物有否再在吲哚环或苯环以不限数量取代。 - 任何在结构上可从2-（3-羟基环己基）酚通过在酚环之5-位上以烷基、链烯基、环烷甲基、环烷乙基或2-（4-吗啉基）乙基取代所生成之化合物，而不论生成物有否再在己基环以不限数量取代。
|
Canabinoides Sintéticos
- Qualquer composto derivado estruturalmente do 3-(1-naphthoyl)indole ou 1Hindol-3-yl-(1-naphthyl)methanone por substituição no átomo de azoto do anel indol por alcoíl, alceno, cicloalcoílmetil, cicloalcoíletil ou 2-(4-morfolinil)etil, quer seja ou não ainda mais substituído em qualquer extensão do anel indole quer seja ou não ainda mais substituído em qualquer extensão do anel naftaleno. - Qualquer composto derivado estruturalmente do 3-(1-naphthoyl)pyrrole por substituição no átomo de azoto do anel pirrol por alcoíl, alceno, cicloalcoílmetil, cicloalcoíletil ou 2-(4-morpholinyl)ethyl, quer seja ou não ainda mais substituído em qualquer extensão do anel pirrol, quer seja ou não ainda mais substituído em qualquer extensão do anel naftaleno. - Qualquer composto derivado estruturalmente do 1-(1-naphthylmethyl)indene por substituição na posição - 3 do anel indeno por alcoíl, alceno, cicloalcoílmetil, cicloalcoíletil ou 2-(4-morpholinyl)ethyl, quer seja ou não ainda mais substituído em qualquer extensão do anel pirrol, quer seja ou não ainda mais substituído em qualquer extensão do anel naphthyl. - Qualquer composto derivado estruturalmente do 3-phenylacetylindole por substituição no átomo de azoto do anel indole por alcoíl, alceno, cicloalcoílmetil, cicloalcoíletil ou 2-(4-morpholinyl)ethyl, quer seja ou não ainda mais substituído em qualquer extensão do anel indole e quer seja ou não substituído em qualquer extensão do anel fenil. - Qualquer composto derivado estruturalmente do 2-(3-hydroxycyclohexyl)phenol por substituição na posição - 3 do anel fenól por alcoíl, alceno, cicloalcoílmetil, cicloalcoíletil ou 2-(4-morpholinyl)ethyl, quer seja ou não ainda mais substituído em qualquer extensão do anel ciclohexil. |
|
| 19 | 1-（1-萘甲酰基）-4-戊氧基萘 | CRA-13, CB-13 | Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone |
| 20 | [1-（5-氟戊基）-1H-吲哚-3-基]（萘-1-基）甲酮 | AM-2201 | [1-(5-Fluoropentyl)-1H-indol-3-yl](naphthalen-1-yl)methanone |
| 21 | 哌乙酯 | Ethylphenidate | ethyl phenyl(piperidin-2-yl)acetate |
| 22 | 1-（2-噻吩基）-N-甲基-2-丙胺 | Methiopropamine(MPA) | N-methyl-1-(thiophen-2-yl)propan-2-amine |
| 23 | N-（1-甲氧基羰基-2,2-二甲基丙基）-1-（环己基甲基）吲哚-3-甲酰胺 | MDMB-CHMICA | methyl N[1-(cyclohexylmethyl)-1H-indol-3-yl] carbonyl3-methyl-L-valinate |
| 24 | N-（1-金刚烷基）-1-（5-氟戊基）吲唑-3-甲酰胺 | 5F-APINACA (5F-AKB-48) | N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide |
| 25 | [1-（5-氟戊基）-1H-吲哚-3-基]（2,2,3,3-四甲基环丙基）甲酮 | XLR-11 | [1-(5-fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone |
| 26 | N-（1-氨甲酰基-2-甲基丙基）-1-（环己基甲基）-吲唑-3-甲酰胺 | AB-CHMINACA | N-[(2S)-1-amino-3-methyl-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide |
| 27 | 5F-ADB/ 5F-MDMB-PINACA | 5F-ADB/5F-MDMB-PINACA | methyl (2S)-2[1-(fluoropentyl)-1H-indazole-3-carbonyl]amino3,3-dimethylbutanoate |
| 28 | N-（1-氨甲酰基-2-甲基丙基）-1-戊基吲唑-3-甲酰胺 | AB-PINACA | N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-pentyl-1H-indazole-3-carboxamide |
| 29 | 1-戊基-3-（2,2,3,3-四甲基环丙甲酰基）吲哚 | UR-144 | (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone |
| 30 | 1-（5-氟戊基）吲哚-3-甲酸-8-喹啉酯 | 5F-PB-22 | quinolin-8-yl 1- (5-fluoropentyl)-1H-indole-3-carboxylate |
| 31 | 4-氟苯丙胺 | 4-Fluoroamphetamine (4-FA) | 1-(4-fluorophenyl)propan-2-amine |
| 32 | ADB-FUBINACA | ADB-FUBINACA | N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide |
| 33 | FUB-AMB (MMB-FUBINACA, AMB-FUBINACA) | FUB-AMB (MMB-FUBINACA, AMB-FUBINACA) | Methyl(2S)-2-({1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3-methylbutanoate |
| 34 | CUMYL-4CN-BINACA | CUMYL-4CN-BINACA | 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide |
| 35 | ADB-CHMINACA (MAB-CHMINACA) | ADB-CHMINACA (MAB-CHMINACA) | N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide |
| 36 | AB-FUBINACA | AB-FUBINACA | N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]indazole-3-carboxamide |
| 37 | 5F-AMB, 5F-AMB-PINACA | 5F-AMB, 5F-AMB-PINACA | methyl 2-({[1-(5-fluoropentyl)-1H-indazol-3yl]carbonyl}amino)-3-methylbutanoate |
| 38 | 5F-MDMB-PICA | 5F-MDMB-PICA | methyl(S)-2-[1-(5-fluoropentyl)-1H-indole-3-carboxamido]-3,3-dimethylbutanoate |
| 39 | 4F-MDMB-BINACA | 4F-MDMB-BINACA | methyl(S)-2-[1-(4-fluorobutyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate |
| 40 | C UMYL-PEGACLON | CUMYL-PEGACLON | 5-pentyl-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one |
| 41 | MDMB-4en-PINACA | MDMB-4en-PINACA | methyl 3,3-dimethyl-2-[1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido]butanoate |
| 本附表所列物质之可能存在之衍生物及盐类，以及由该等物质配有其他不论其作用如何之复合物调制而成之所有制剂。 | |||
表二 C
编辑| 编号 | 中文名称 | 葡文名称 | 化学名称∕结构 |
|---|---|---|---|
| 1 | 异戊巴比妥 | Amobarbital | 5-ethyl-5-isopentylbarbituric acid |
| 2 | 丁丙诺啡 | Buprenorfina | 2l-cyclopropyl-7-α-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine |
| 3 | 布他比妥 | Butalbital | 5-allyl-5-isobutylbarbituric acid |
| 4 | 环巴比妥 | Ciclobarbital | 5-(1-cyclohexen-1-yl)-5-ethylbarbituric acid |
| 5 | 伽马-烃丁酸 | GHB | γ-hydroxybutyric acid |
| 6 | 格鲁米特 | Glutetamida | 2-ethyl-2-phenylglutarimide |
| 7 | 氯胺酮 | Ketamina | (±)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone |
| 8 | 甲氯喹酮 | Mecloqualona | 3-(o-chlorophenyl)-2-methyl-4(3H)-quinazolinone |
| 9 | 甲喹酮 | Metaqualona | 2-methyl-3-o-tolyl-4(3H)-quinazolinone |
| 10 | 喷他佐辛 | Pentazocina | (2R*,6R*,11R*)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2- butenyl)-2,6-methano-3-benzazocin-8-ol |
| 11 | 戊巴比妥 | Pentobarbital | 5-ethyl-5-(1-methylbutyl)barbituric acid |
| 12 | 司可巴比妥 | Secobarbital | 5-allyl-5-(1-methylbutyl)barbituric acid |
| 13 | 2-（3-甲氧基苯基）-2-乙氨基环己酮 | Methoxetamine (MXE) | 2-(3-methoxyphenyl)-2-(ethylamino)-cyclohexanone |
| 14 | 氟胺酮 | 2-Fluorodeschloroketamine, 2-FDCK | 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one |
| 本附表所列物质之可能存在之盐类。 | |||
表三
编辑| 1 | 制剂：醋氢可待因；可待因；双氢可待因；乙基吗啡；吗啉乙基吗啡；6-烟碱可待因；烟碱酰二可待因；去甲可待因。以上制剂与其他一种或数种成分调配、每剂量单位药物含量不超过100毫克且其浓度不超过整个制剂的2.5%。 |
| 2 | 丙吡胺制剂：每剂量单位含丙吡胺不超过100毫克并且与至少等量的甲基纤维素相调配。 |
| 3 | 右旋丙氧吩制剂：口服制剂，其每剂量单位含有不超过135毫克的右旋丙氧吩咸或其浓度不超过整个制剂的2.5%，条件是这类制剂不含有根据1971年精神药物公约加以管制的任何物品。 |
| 4 | 可卡因制剂：所含可卡因以可卡因咸计算不超过0.1%；和阿片或吗啡制剂：所含吗啡以无水吗啡咸计算不超过0.2%，且因与一种或数种其他成分调配，致使其中的药物不能以简便方法回收或其分量构成对公众健康的危害。 |
| 5 | 氰苯哌酸制剂：每剂量单位含有不超过0.5毫克的氰苯哌酸并含有至少相当于氰苯哌酸剂量5%的硫酸颠茄咸。 |
| 6 | 地芬诺酯制剂：每剂量单位含有以咸计算不超过2.5毫克的地芬诺酯并含有至少相当于地芬诺酯剂量1%的硫酸颠茄咸。 |
| 7 | 复方阿片吐根散制剂：
10%阿片粉； 10%吐根散； 80%不含任何药物的其他粉状成分，细混合。 |
| 8 | 符合本表所列任一配方的制剂以及此项制剂与不含任何药物的原料的混合物。 |
表四
编辑| 编号 | 中文名称 | 葡文名称 | 化学名称∕结构 |
|---|---|---|---|
| 1 | 二丙烯基巴比妥 | Alobarbital | 5,5-diallylbarbituric acid |
| 2 | 阿普唑仑 | Alprazolam | 8-chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine |
| 3 | 二乙胺苯丙酮 | Amfepramona, Dietilpropiona | 2-(diethylamino)propiophenone |
| 4 | 氨苯恶唑啉 | Aminorex | 2-amino-5-phenyl-2-oxazoline |
| 5 | 巴比妥 | Barbital | 5,5-diethylbarbituric acid |
| 6 | 苄甲苯异丙胺 | Benzefetamina | N-benzyl-N,α-dimethylphenethylamine |
| 7 | 溴西泮 | Bromazepam | 7-bromo-1,3-dihydro-5-(2-pyridyl)-2H-1,4-benzodiazepine-2-one |
| 8 | 溴噻二氮䓬 | Brotizolam | 2-bromo-4-(o-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-s-triazolo[4,3- a][1,4]diazepine |
| 9 | 丁巴比妥 | Butobarbital | 5-butyl-5-ethylbarbituric acid |
| 10 | 卡马西泮 | Camazepam | 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4- benzodiazepine-2-one dimethylcarbamate (ester) |
| 11 | 凯他唑仑 | Cetzolam | 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4H-[1,3]oxazino[3,2-d][1,4]benzodiazepine-4,7(6H)-dione |
| 12 | 氯巴占 | Clobazam | 7-chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione |
| 13 | 氯硝西泮 | Clonazepam | 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepine-2-one |
| 14 | 氯氮䓬 | Clorazepato | 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3- carboxylic acid |
| 15 | 利眠宁 | Clordiazepóxido | 7-chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepine-4-oxide |
| 16 | 氯噻西泮 | Clotiazepam | 5-(o-chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-2H-thieno[2,3-e]- 1,4-diazepine-2-one |
| 17 | 氯恶唑仑 | Cloxazolam | 10-chloro-11b-(o-chlorophenyl)-2,3,7,11b-tetrahydro-oxazolo-[3,2- d][1,4]benzodiazepine-6(5H)-one |
| 18 | 地洛西泮 | Delorazepam | 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepine-2-one |
| 19 | 安定 | Diazepam | 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepine-2-one |
| 20 | 舒乐安定 | Estazolam | 8-chloro-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine |
| 21 | 乙氯维诺 | Etclorvinol | 1-chloro-3-ethyl-1-penten-4-yn-3-ol |
| 22 | 乙非他明，N-乙基苯丙胺 | Etilanfetamina, N-etilanfetamina | N-ethylamphetamine-α-methylphenethylamine |
| 23 | 氯氟卓乙酯 | Etil-loflazepato | ethyl-7-chloro-5-(o-fluorophenyl)-2,3-dihydro-2-oxo-1H-1,4- benzodiazepine-3-carboxylate |
| 24 | 炔己蚁胺 | Etinamato | 1-ethynylcyclohexanol carbamate |
| 25 | 芬坎法明 | Fencanfamina | N-ethyl-3-phenyl-2-norbornanamine |
| 26 | 苯巴比妥 | Fenobarbital | 5-ethyl-5-phenylbarbituric acid |
| 27 | 芬普雷斯 | Fenproporex | (±)-3-[(α-methylphenylethyl)amino]propionitrile |
| 28 | 氟地西泮 | Fludiazepam | 7-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4- benzodiazepine-2-one |
| 29 | 氟硝西泮 | Flunitrazepam | 5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-7-2H-1,4-benzodiazepine-2-one |
| 30 | 氟安定 | Flurazepam | 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-1,3-dihydro- 2H-1,4-benzodiazepine-2-one |
| 31 | 哈拉西泮 | Halazepam | 7-chloro-1,3-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)-2H-1,4- benzodiazepine-2-one |
| 32 | 卤恶唑仑 | Haloxazolam | 10-bromo-11b-(o-fluorophenyl)-2,3,7,11b-tetrahydroox azolo[3,2-d] [1,4]benzodiazepine-6(5H)-one |
| 33 | 勒非他明，二甲胺基二苯乙烷 | Lefetamina, SPA | (–)-N,N-dimethyl-1,2-diphenylethylamine |
| 34 | 氯普唑仑 | Loprazolam | 6-(o-chlorophenyl)-2,4-dihydro-2-[(4-methyl-1-piperazinyl)methylene]-8-nitro-1H-imidazo[1,2-a][1,4]benzodiazepine-1-one |
| 35 | 芬拉西泮 | Lorazepam | 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4- benzodiazepine-2-one |
| 36 | 氯甲西泮 | Lormetazepam | 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-1-methyl-2H-1,4- benzodiazepine-2-one |
| 37 | 马吲哚 | Mazindol | 5-(p-chlorophenyl)-2,5-dihydro-3H-imidazo[2,1-a]isoindol-5-ol |
| 38 | 美逹西泮 | Medazepam | 7-chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine |
| 39 | 美芬雷斯 | Mefenorex | N-(3-chloropropyl)-α-methylphenethylamine |
| 40 | 甲丙氨酯 | Meprobamato | 2-methyl-2-propyl-1,3-propanediol, dicarbamate |
| 41 | 双苯斯酮胺 | Mesocarbe | 3-(α-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine |
| 42 | 甲基苯巴比妥 | Metilfenobarbital | 5-ethyl-1-methyl-5-phenylbarbituric acid |
| 43 | 甲乙哌啶酮 | Metiprilona | 3,3-diethyl-5-methyl-2,4-piperidine-dione |
| 44 | 咪逹唑仑 | Midazolam | 8-chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo[1,5- a][1,4]benzodiazepine |
| 45 | 硝甲西泮 | Nimetazepam | 1,3-dihydro-1-methyl-7-nitro-5-phenyl-2H-1,4-benzodiazepine-2-one |
| 46 | 硝西泮 | Nitrazepam | 1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepine-2-one |
| 47 | 去甲西泮 | Nordazepam | 7-chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepine-2-one |
| 48 | 去甲羟安定 | Oxazepam | 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepine-2-one |
| 49 | 恶唑仑 | Oxazolam | 10-chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenyloxazolo[3,2- d][1,4]benzodiazepine-6(5H)-one |
| 50 | 匹吗啉 | Pemolina | 2-amino-5-phenyl-2-oxazolin-4-one(=2-imino-5-phenyl-4-oxazolidinone) |
| 51 | 匹那西泮 | Pinazepam | 7-chloro-1,3-dihydro-5-phenyl-1-(2-propynyl)-2H-1,4-benzodiazepine- 2-one |
| 52 | 哌苯甲醇 | Pipradol | 1,1-diphenyl-1-(2-piperidyl)methanol |
| 53 | 焦二异丁基酮 | Pirovalerona | 4'-methyl-2-(1-pyrrolidinyl)valerophenone |
| 54 | 普拉西泮 | Prazepam | 7-chloro-1-(cyclopropylmethyl)-1,3-dihydro-5-phenyl-2H-1,4- benzodiazepine-2-one |
| 55 | 环乙丙甲胺 | Propil-hexedrina | 1-cyclohexyl-2-methylaminopropane |
| 56 | 仲丁比妥 | Secbutabarbital | 5-sec-butyl-5-ethylbarbituric acid |
| 57 | 替马西泮 | Temazepam | 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4- benzodiazepine-2-one |
| 58 | 四氢西泮 | Tetrazepam | 7-chloro-5-(1-cyclohexen-1-yl)-1,3-dihydro-1-methyl-2H-1,4- benzodiazepine-2-one |
| 59 | 三唑仑 | Triazolam | 8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4] benzodiazepine |
| 60 | 乙烯比妥 | Vinilbital | 5-(1-methylbutyl)-5-vinylbarbituric acid |
| 61 | 唑吡旦 | Zolpidem | N,N,6-trimethyl-2-p-tolylimidazo[1,2-a]pyridine-3-acetamide |
| 62 | 芬纳西泮 | Phenazepam | 7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one |
| 63 | 氟阿普唑仑 | Flualprazolam | 8-chloro-6-(2-fluoro-phenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine |
| 64 | 依替唑仑 | Etizolam | 4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine |
| 65 | 氯氮唑仑 | Clonazolam | 6-(2-chlorophenyl)-1-methyl-8-nitro-4H- -benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine |
| 66 | 二氯西泮 | Diclazepam | 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3--dihydro-2H-benzo[e][1,4]diazepin-2-one |
| 67 | 氟溴唑仑 | Flubromazolam | 8-bromo-6-(2-fluorophenyl)-1-methyl-4H--benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine |
| 本附表所列物质之可能存在之盐类。 | |||
表五
编辑| 编号 | 中文名称 | 葡文名称 | 化学名称∕结构 |
|---|---|---|---|
| 1 | 醋酸酐 | Anidrido acético | acetic oxide |
| 2 | N-乙酰邻氨基苯酸 | Ácido N-acetilantranílico | 2-(acetylamino)-benzoic acid |
| 3 | 麻黄碱 | Efedrina | [R-(R*,S*)]-[1-(methylamino)ethyl]-benzenemethanol |
| 4 | 麦角新碱 | Ergometrina | [8ß(S)]- 9,10-didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8-carboxamide |
| 5 | 麦角胺 | Ergotamina | 12'-hydroxy-2'-methyl-5'α-(phenyl-methyl)-ergotaman-3',6',18'-trione |
| 6 | 异黄樟脑 | Isosafrole | 5-(1-propenyl)- 1,3-benzodioxole |
| 7 | 麦角酸 | Ácido lisérgico | (8ß)-9,10-didehydro-6-methylergoline-8-carboxylic acid |
| 8 | 3,4-亚甲基二氧苯基-2-丙酮 | 3,4-Metilenodioxif enil-2- propanona | 1-[3,4-(methylenedioxy)phenyl]- 2-propanone |
| 9 | 去甲麻黄碱 | Norefedrina | (R*, S*)-α-(1-aminoethyl)benzenemethanol |
| 10 | 1-苯基-2-丙酮 | Fenilacetona /1-Fenil-2-propano na | 1-phenyl-2-propanone |
| 11 | 胡椒醛 | Piperonal | 1,3-benzodioxole-5-carboxaldehyde |
| 12 | 高锰酸钾 | Permanganato de potássio | permanganic acid (HMnO4) potassium salt |
| 13 | 伪麻黄碱 | Pseudoefedrina | [S-(R*,R*)].--[1-(methylamino)ethyl]-benzenemethanol |
| 14 | 黄樟脑 | Safrole | 5-(2-propenyl)-1,3-benzodioxole |
| 15 | 苯乙酸 | Ácido fenilacético | benzeneacetic acid |
| 16 | α-苯乙酰乙腈 | alfafenilacetoacetonitrilo | alpha-phenylacetoacetonitrile |
| 17 | 4-苯胺-N-苯乙基哌啶 | 4-Anilino-N-phenethylpiperidine (ANPP) | N-phenyl-1-(2-phenylethyl)piperidin-4-amine |
| 18 | N-苯乙基-4-哌啶酮 | N-Phenethyl-4-piperidone (NPP) | 1-(2-phenylethyl)piperidin-4-one |
| 19 | 3,4-亚甲基二氧苯基-2-丙酮甲基缩水甘油 | 3,4-MDP-2-P methyl glycidate | 2-oxiranecarboxylic acid, 3-(1,3-benzodioxol-5-yl)-2-methyl-, methyl ester |
| 20 | 3,4-亚甲基二氧苯基-2-丙酮甲基缩水甘油酸 | 3,4-MDP-2-P methyl glycidic acid | 2-oxiranecarboxylic acid, 3-(1,3-benzodioxol-5-yl)-2- methyl- |
| 21 | α-乙酰乙酰苯胺 | alpha-phenylacetoacetamide (APAA) | benzeneacetamide, α-acetyl- |
| 22 | α-苯乙酰乙酸甲酯（MAPA） | Methyl alpha-phenylacetoacetate (MAPA) | methyl 3-oxo-2-phenylbutanoate |
| 23 | 4-AP | 4-AP | 4-piperidinamine, N-phenyl- |
| 24 | 1-boc-4-A P | 1-boc-4-AP | 4-(phenylamino)-1-piperidinecarboxylic acid, 1,1-dimethylethyl ester |
| 25 | 去甲芬太尼 | Norfentanyl | propanamide, N-phenyl-N-4-piperidinyl- |
| 本附表所列物质之可能存在之盐类。 | |||
| 本附表所列物质的具有特定化学名称的异构物，但明确不列入本附表的异构物除外。 | |||
表六
编辑| 编号 | 中文名称 | 葡文名称 | 化学名称∕结构 |
|---|---|---|---|
| 1 | 丙酮 | Acetona | 2-propanone |
| 2 | 邻氨基苯甲酸 | Ácido antranílico | 2-aminobenzoic acid |
| 3 | 乙醚 | Éter etílico | 1,1’-oxybis[ethane] |
| 4 | 盐酸 | Ácido clorídrico | hydrochloric acid |
| 5 | 甲基乙基酮/丁酮 | Metiletilcetona/Butanona | 2-butanone |
| 6 | 哌啶 | Piperidina | piperidine |
| 7 | 硫酸 | Ácido sulfúrico | sulfuric acid |
| 8 | 甲苯 | Tolueno | methyl-benzene |
| 本附表所列物质之可能存在之盐类，但盐酸盐及硫酸盐除外。 | |||
Public domainPublic domainfalsefalse